• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Potent cytodifferentiating agents related to hexamethylenebisacetamide.与六甲撑双乙酰胺相关的强效细胞分化剂。
Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5542-6. doi: 10.1073/pnas.88.13.5542.
2
Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.第二代杂化极性化合物是转化细胞分化的有效诱导剂。
Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5705-8. doi: 10.1073/pnas.93.12.5705.
3
A new group of potent inducers of differentiation in murine erythroleukemia cells.一组新型的强效诱导小鼠红白血病细胞分化的物质。
Proc Natl Acad Sci U S A. 1976 Mar;73(3):862-6. doi: 10.1073/pnas.73.3.862.
4
Inducers of erythroleukemic differentiation. Relationship of structure to activity among planar-polar compounds.促红细胞白血病分化诱导剂。平面极性化合物的结构与活性的关系。
J Biol Chem. 1978 Jun 25;253(12):4214-8.
5
Vincristine-resistant erythroleukemia cell line has marked increased sensitivity to hexamethylenebisacetamide-induced differentiation.长春新碱耐药的红白血病细胞系对六亚甲基双乙酰胺诱导的分化具有显著增强的敏感性。
Proc Natl Acad Sci U S A. 1988 Jun;85(11):3835-9. doi: 10.1073/pnas.85.11.3835.
6
Bis-pyrrolyl-tetrazolyl derivatives as hybrid polar compounds: A case of lipophilic functional bioisosterism with bis-acetamides.双吡咯-四唑基衍生物作为混合极性化合物:双乙酰胺的亲脂性功能生物等排体案例。
Eur J Med Chem. 2012 Apr;50:75-80. doi: 10.1016/j.ejmech.2012.01.041. Epub 2012 Feb 2.
7
Differentiation inducers modulate cytokine signaling pathways in a murine erythroleukemia cell line.
Cancer Res. 1998 Feb 1;58(3):556-61.
8
New designed HMBA agents as inducers of erythroleukemia cell differentiation.新型设计的HMBA制剂作为红白血病细胞分化诱导剂。
Chin Med Sci J. 2002 Mar;17(1):27-31.
9
Potential antitumor agents. 23.(1) Cytotoxic and differentiating activity of compounds related to hexamethylenebisacetamide.潜在的抗肿瘤药物。23.(1)与六亚甲基双乙酰胺相关化合物的细胞毒性和分化活性。
Farmaco. 1993 Nov;48(11):1503-13.
10
Hexamethylenebisacetamide-induced erythroleukemia cell differentiation involves modulation of events required for cell cycle progression through G1.六亚甲基双乙酰胺诱导的红白血病细胞分化涉及对细胞周期通过G1期进展所需事件的调节。
Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6746-50. doi: 10.1073/pnas.90.14.6746.

引用本文的文献

1
Histone deacetylase inhibition reduces deleterious cytokine release induced by ingenol stimulation.组蛋白去乙酰化酶抑制可减少 ingenol 刺激诱导的有害细胞因子释放。
Biochem Pharmacol. 2022 Jan;195:114844. doi: 10.1016/j.bcp.2021.114844. Epub 2021 Nov 18.
2
Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors.用双组蛋白去乙酰化酶和去甲基化酶抑制剂靶向CoREST复合物。
Nat Commun. 2018 Jan 4;9(1):53. doi: 10.1038/s41467-017-02242-4.
3
Suberoylanilide hydroxamic acid (SAHA) reverses chemoresistance in head and neck cancer cells by targeting cancer stem cells via the downregulation of nanog.辛二酰苯胺异羟肟酸(SAHA)通过下调纳米管蛋白(nanog)靶向癌症干细胞,从而逆转头颈部癌细胞的化疗耐药性。
Genes Cancer. 2015 Mar;6(3-4):169-81. doi: 10.18632/genesandcancer.54.
4
Lead optimization of HMBA to develop potent HEXIM1 inducers.对六亚甲基双乙酰胺(HMBA)进行先导化合物优化,以开发强效的HEXIM1诱导剂。
Bioorg Med Chem Lett. 2014 Mar 1;24(5):1410-3. doi: 10.1016/j.bmcl.2014.01.025. Epub 2014 Jan 17.
5
The synthesis and evaluation of N1-(4-(2-[18F]-fluoroethyl)phenyl)-N8-hydroxyoctanediamide ([18F]-FESAHA), a PET radiotracer designed for the delineation of histone deacetylase expression in cancer.N1-(4-(2-[18F]-氟乙基)苯基)-N8-羟基辛二酰胺([18F]-FESAHA)的合成与评价,一种用于描绘癌症中组蛋白去乙酰化酶表达的 PET 放射性示踪剂。
Nucl Med Biol. 2011 Jul;38(5):683-96. doi: 10.1016/j.nucmedbio.2010.12.008. Epub 2011 Mar 3.
6
The inhibitors of histone deacetylase suberoylanilide hydroxamate and trichostatin A release nitric oxide upon oxidation.组蛋白去乙酰化酶抑制剂丁氧羰基邻氨甲酰苯甲酸和曲古抑菌素 A 在氧化时会释放一氧化氮。
Free Radic Biol Med. 2009 Aug 15;47(4):419-23. doi: 10.1016/j.freeradbiomed.2009.05.011. Epub 2009 May 15.
7
Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells.组蛋白去乙酰化酶抑制剂在正常细胞中触发G2检查点,而该检查点在肿瘤细胞中存在缺陷。
Mol Biol Cell. 2000 Jun;11(6):2069-83. doi: 10.1091/mbc.11.6.2069.
8
Anti-tumour activity in vitro and in vivo of selective differentiating agents containing hydroxamate.含异羟肟酸的选择性分化剂的体外和体内抗肿瘤活性
Br J Cancer. 1999 Jun;80(8):1252-8. doi: 10.1038/sj.bjc.6690493.
9
A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases.一类转化细胞分化的杂交极性诱导剂可抑制组蛋白脱乙酰基酶。
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):3003-7. doi: 10.1073/pnas.95.6.3003.
10
Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.第二代杂化极性化合物是转化细胞分化的有效诱导剂。
Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):5705-8. doi: 10.1073/pnas.93.12.5705.

本文引用的文献

1
Hemoglobin synthesis in murine virus-induced leukemic cells in vitro: stimulation of erythroid differentiation by dimethyl sulfoxide.体外小鼠病毒诱导白血病细胞中的血红蛋白合成:二甲基亚砜对红系分化的刺激作用
Proc Natl Acad Sci U S A. 1971 Feb;68(2):378-82. doi: 10.1073/pnas.68.2.378.
2
Chemical differentiating agents. Differentiation of HL-60 cells by hexamethylenebis[acetamide] analogues.化学分化剂。六亚甲基双[乙酰胺]类似物对HL-60细胞的分化作用。
J Med Chem. 1987 Feb;30(2):405-9. doi: 10.1021/jm00385a025.
3
Phase I clinical and pharmacokinetic study of hexamethylene bisacetamide (NSC 95580) administered as a five-day continuous infusion.六甲撑双乙酰胺(NSC 95580)五日持续静脉输注的I期临床及药代动力学研究
Cancer Res. 1987 Jan 15;47(2):617-23.
4
Protein kinase C activity and hexamethylenebisacetamide-induced erythroleukemia cell differentiation.蛋白激酶C活性与六亚甲基双乙酰胺诱导的红白血病细胞分化
Proc Natl Acad Sci U S A. 1987 Aug;84(15):5282-6. doi: 10.1073/pnas.84.15.5282.
5
Phase I trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals.
Cancer Res. 1988 Dec 15;48(24 Pt 1):7304-9.
6
Induction of differentiation of human promyelocytic leukemia cells (HL60) by metabolites of hexamethylene bisacetamide.六亚甲基双乙酰胺代谢产物诱导人早幼粒细胞白血病细胞(HL60)分化
Cancer Res. 1988 Jul 1;48(13):3613-6.
7
Studies and perspectives of protein kinase C.蛋白激酶C的研究与展望
Science. 1986 Jul 18;233(4761):305-12. doi: 10.1126/science.3014651.
8
Effect on in vivo tumorigenicity of lengthy exposure of human colon cancer cells to the differentiation agent hexamethylene bisacetamide.人结肠癌细胞长时间暴露于分化剂六亚甲基双乙酰胺对其体内致瘤性的影响。
Cancer Lett. 1989 Nov 15;48(1):53-8. doi: 10.1016/0304-3835(89)90202-4.
9
Differential expression of protein kinase C isozymes and erythroleukemia cell differentiation.蛋白激酶C同工酶的差异表达与红白血病细胞分化
J Biol Chem. 1989 Nov 5;264(31):18414-8.
10
Polar/apolar chemical inducers of differentiation of transformed cells: strategies to improve therapeutic potential.转化细胞分化的极性/非极性化学诱导剂:提高治疗潜力的策略
Proc Natl Acad Sci U S A. 1989 Aug;86(16):6358-62. doi: 10.1073/pnas.86.16.6358.

与六甲撑双乙酰胺相关的强效细胞分化剂。

Potent cytodifferentiating agents related to hexamethylenebisacetamide.

作者信息

Breslow R, Jursic B, Yan Z F, Friedman E, Leng L, Ngo L, Rifkind R A, Marks P A

机构信息

Department of Chemistry, Columbia University, New York, NY 10027.

出版信息

Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5542-6. doi: 10.1073/pnas.88.13.5542.

DOI:10.1073/pnas.88.13.5542
PMID:2062836
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC51913/
Abstract

Bishydroxamic acids are effective inducers of differentiation in murine erythroleukemia cells. Flexible analogs of suberic acid bisdimethylamide are approximately 100 times as active as the parent compound or hexamethylenebisacetamide. They also induce differentiation of human promyelocytic leukemia cells (HL-60) and a subclone of human colon carcinoma cells (HT-29-U4). Some rigid bishydroxamic acids with benzene rings in the spacers are even more active toward murine erythroleukemia cells but show curious biological differences. In contrast to the flexible molecules, those with benzene spacers show poor activity toward HL-60 cells; they also have different geometric requirements, and they are not additive with hexamethylenebisacetamide in their effect. It is likely that rigid bishydroxamic acids, with a benzene ring spacer, induce differentiation by a different mechanism in spite of their chemical resemblance to the flexible bisamide and bishydroxamic acid inducers.

摘要

双异羟肟酸是小鼠红白血病细胞分化的有效诱导剂。辛二酸双二甲酰胺的柔性类似物的活性约为母体化合物或六亚甲基双乙酰胺的100倍。它们还能诱导人早幼粒细胞白血病细胞(HL-60)和人结肠癌细胞亚克隆(HT-29-U4)的分化。一些在间隔基中有苯环的刚性双异羟肟酸对小鼠红白血病细胞的活性甚至更高,但表现出奇特的生物学差异。与柔性分子相比,带有苯间隔基的分子对HL-60细胞的活性较差;它们也有不同的几何要求,并且在作用上与六亚甲基双乙酰胺没有加和性。尽管带有苯环间隔基的刚性双异羟肟酸在化学结构上与柔性双酰胺和双异羟肟酸诱导剂相似,但它们可能通过不同的机制诱导分化。